However, it is known that a high proportion BRCA1 and BRCA2 carriers do not have a significant family history of BC or OC.22 More recent developments in personalised cancer management for individuals with GPV have resulted in lowered thresholds for germline testing with increasing numbers of individuals now eligible. This evidence concerns the gene BRCA2 and breast cancer.